Showing results (811-820 of 861) with videos related to

Sort By:
Pageof 87
International Journal of Colorectal Disease|January 13, 2021
A European snapshot of psychosocial characteristics and patients' perspectives of faecal incontinence-do they correlate with current scoring systems?Felicity Creamer, Alessandra Orlando, Maximillian Brunner, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 29, 2025
Impact of Low-Dose Computed Tomography Findings on Cigarette Smoking Cessation Among High-Risk Adults Participating in Lung Cancer ScreeningEvangelos Katsampouris, Amyn Bhamani, Fanta Bojang, et al.
The Journal of Clinical Investigation|January 8, 2019
Lineage-specific events underlie aortic root aneurysm pathogenesis in Loeys-Dietz syndromeElena Gallo MacFarlane, Sarah J Parker, Joseph Y Shin, et al.
The British Journal of Psychiatry : the Journal of Mental Science|August 3, 2004
War-related psychological stressors and risk of psychological disorders in Australian veterans of the 1991 Gulf WarJillian F Ikin, Malcolm R Sim, Mark C Creamer, et al.
Tobacco Control|May 31, 2023
Update to the design and methods of the PATH Study, Wave 4 (2016-2017)Jean D Opsomer, Sylvia Dohrmann, Ralph DiGaetano, et al.
Thorax|February 2, 2026
Upstaging of screen-detected lung cancers during diagnostic assessmentMonica L Mullin, Priyam Verghese, Chuen R Khaw, et al.
Applied and Environmental Microbiology|November 1, 2016
Benzoate- and Salicylate-Tolerant Strains of Escherichia coli K-12 Lose Antibiotic Resistance during Laboratory EvolutionKaitlin E Creamer, Frederick S Ditmars, Preston J Basting, et al.
Neurorehabilitation|August 9, 2024
Traumatic brain injury and sleep in military and veteran populations: A literature reviewJeremy Landvater, Sharon Kim, Keenan Caswell, et al.
European Radiology|July 4, 2026
Conservative management of < 3cm anterior mediastinal lesions in lung cancer screening is safeAmyn Bhamani, Chuen R Khaw, Ruth Prendecki, et al.
Breast Cancer Research : BCR|September 4, 2019
A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive breast cancer (TEAL study)Tejal A Patel, Joe E Ensor, Sarah L Creamer, et al.
Pageof 87